Gairdner Foundation

Last updated

The Gairdner Foundation is a non-profit organization devoted to the recognition of outstanding achievements in biomedical research worldwide. It was created in 1957 by James Arthur Gairdner to recognize and reward the achievements of medical researchers whose work contributes significantly to improving the quality of human life. Since the first awards were made in 1959, the Gairdner Awards have become Canada's most prestigious medical awards, recognizing and celebrating the research of the world’s best and brightest biomedical researchers. Since 1959, more than 390 Canada Gairdner Awards have been given to scientists from 35 countries; of these recipients, 98 have subsequently gone on to win a Nobel Prize. [1]

Contents

History

The Gairdner Foundation was created in 1957 by James Arthur Gairdner (1893-1971). Known as Big Jim to his grandchildren, he was, indeed, a larger than life figure. Described by his friends as a talented maverick and visionary, Gairdner was a colorful personality who lived large. He was, by turns, an athlete, a soldier, a stockbroker, a businessman, a philanthropist and a landscape painter. When he died, he left his private estate to the Town of Oakville as an art gallery, which still operates today. [2]

While he had always had an interest in medicine, it was the onset of severe arthritis in his early 50s that led Gairdner to become involved with the newly created Canadian Arthritis and Rheumatism Society. In 1957 he donated $500,000 to establish a foundation to recognize major research contributions in the conquest of disease and human suffering. The Gairdner Foundation was thus born, which was to be his most lasting legacy.

Gairdner’s decision to create awards that recognize outstanding discoveries by the world’s top scientists was, and continues to be, an act of extraordinary vision. Much of his original instruction regarding the process of selection and awarding of the prizes remains in place today, contributing to the current stature of the Canada Gairdner Awards.

Awards

There are three types of awards:

Each laureate receives $100,000 CDN that they can put towards anything they wish. Laureates in the past have put their winnings towards their labs, their research or even paid for their niece to attend medical school. [3] The Canada Gairdner Awards are supported by the governments of Canada, Alberta, Quebec and Ontario. In February 2008 the Federal Government announced a $20 million allocation to the Gairdner Foundation to increase the prizes to $100,000 each, and institute a new individual prize in Global Health. Commencing in 2009, the Awards have been renamed the Canada Gairdner International Awards.

Board of directors

A 14-member Board of Directors consisting of three members of the Gairdner family and twelve leading figures in Canadian business and scientific life oversee the work of the Foundation. The Directors provide logistical support to the Medical Review Panel and the Medical Advisory Board, and are also engaged in fundraising for the Foundation and planning for its future growth.

Awards Adjudication Committees

The Gairdner reputation rests squarely on the outstanding quality of its adjudication process. The model for adjudication that James Gairdner outlined in 1959 remains essentially intact.

The nominations for the Canada Gairdner International Awards go through a two-stage adjudication process. The first assessment is done by The Medical Review Panel (MRP), a group of over 30 leading scientists from across Canada. They select a short list of approximately 20 candidates, which is then given to The Medical Advisory Board (MAB), composed of 24 Canadian and international scientists. Each January, the MAB meets in Toronto to review the nominations submitted by the Medical Review Panel. After an in-depth study and lengthy discussion of each nominee, comparing their work with others in their respective field, secret ballots are cast and the five annual winners chosen.

The Canada Gairdner Global Health Award was initiated in 2009 – when Gairdner received a $20 million allocation from the Government of Canada – and it quickly became the most important award in the field. The winners are selected by the Global Health Advisory Committee, a group of 12 domestic and international scientists. After a comprehensive evaluation process, the committee selects an eventual winner from the pool of submitted nominations through a secret ballot. [4]

The Canada Gairdner Wightman Award recipient is selected by the Wightman Committee, a group of nine recognized leaders in Canadian and international medicine. With careful inquiry and thorough discussion, the Committee chooses the most outstanding candidate by secret ballot.

Student Outreach Program

Along with recognizing the life-changing work of laureates, The Gairdner Foundation also strives to inspire the next generation of students to consider a career in the health sciences through its National Program, which sees current and past awardees travel across to universities across Canada to speak to medical and science faculty. Since 2001, this has also included lecture series aimed specifically at selected senior high school and CEGEP students.

The lectures, which are each 15 to 20 minutes long, provide a chance for accomplished scientists to connect and share their experiences with younger audiences. Laureates discuss their award-winning research as well as the journeys that led them to pursue careers in science, engaging with and encouraging high school students to similarly work towards achieving their own professional goals.

Lectures take place in various towns and cities across the country, including Charlottetown, Kingston, Toronto (at York University and University of Toronto), Ottawa, Montreal, Waterloo, London, Guelph, Winnipeg, Saskatoon, Edmonton, Calgary and Vancouver. At several universities, these lectures have become part of the overall student recruitment program.

For information on 2017 Student Outreach programs, please visit the Foundation's website.

Gairdner National Program

Each October, as part of the Gairdner's mandate to communicate the work of medical researchers to others, the most recent Canada Gairdner awardees, along with awardees from years past, visit universities across Canada to provide academic lectures on their various areas of expertise.

Related Research Articles

<span class="mw-page-title-main">Rosalyn Sussman Yalow</span> American medical physicist

Rosalyn Sussman Yalow was an American medical physicist, and a co-winner of the 1977 Nobel Prize in Physiology or Medicine for development of the radioimmunoassay technique. She was the second woman, and the first American-born woman, to be awarded the Nobel Prize in Physiology or Medicine.

The Shanti Swarup Bhatnagar Prize for Science and Technology (SSB) is a science award in India given annually by the Council of Scientific and Industrial Research (CSIR) for notable and outstanding research, applied or fundamental, in biology, chemistry, environmental science, engineering, mathematics, medicine, and physics. The prize recognizes outstanding Indian work in science and technology. It is the most coveted award in multidisciplinary science in India. The award is named after the founder Director of the Council of Scientific & Industrial Research, Shanti Swarup Bhatnagar. It was first awarded in 1958.

<span class="mw-page-title-main">Joseph L. Goldstein</span> American biochemist

Joseph Leonard Goldstein ForMemRS is an American biochemist. He received the Nobel Prize in Physiology or Medicine in 1985, along with fellow University of Texas Southwestern researcher, Michael Brown, for their studies regarding cholesterol. They discovered that human cells have low-density lipoprotein (LDL) receptors that remove cholesterol from the blood and that when LDL receptors are not present in sufficient numbers, individuals develop hypercholesterolemia and become at risk for cholesterol related diseases, notably coronary heart disease. Their studies led to the development of statin drugs.

The Canada Gairdner International Award is given annually by the Gairdner Foundation at a special dinner to five individuals for outstanding discoveries or contributions to medical science. Receipt of the Gairdner is traditionally considered a precursor to winning the Nobel Prize in Medicine; as of 2020, 98 Nobel Prizes have been awarded to prior Gairdner recipients.

<span class="mw-page-title-main">E. Donnall Thomas</span> American hematologist

Edward Donnall "Don" Thomas was an American physician, professor emeritus at the University of Washington, and director emeritus of the clinical research division at the Fred Hutchinson Cancer Research Center. In 1990 he shared the Nobel Prize in Physiology or Medicine with Joseph E. Murray for the development of cell and organ transplantation. Thomas and his wife and research partner Dottie Thomas developed bone marrow transplantation as a treatment for leukemia.

<span class="mw-page-title-main">Academy of Medical Sciences (United Kingdom)</span> British academic society

The Academy of Medical Sciences is an organisation established in the UK in 1998. It is one of the four UK National Academies, the others being the British Academy, the Royal Academy of Engineering and the Royal Society.

<span class="mw-page-title-main">Madurai Kamaraj University</span> Public state university in Tamil Nadu, India

Madurai Kamaraj University (MKU) is a public state university located in Madurai city, in southern Tamil Nadu, India, that was established in 1966. MKU is one of the 15 universities in India with the University with Potential for Excellence status, which was awarded by the University Grants Commission (UGC) in India. In 2021, the university was awarded an 'A++' grade from the National Assessment and Accreditation Council (NAAC) in its 4th cycle.

<span class="mw-page-title-main">Joan A. Steitz</span> American biochemist

Joan Elaine Argetsinger Steitz is Sterling Professor of Molecular Biophysics and Biochemistry at Yale University and Investigator at the Howard Hughes Medical Institute. She is known for her discoveries involving RNA, including ground-breaking insights into how ribosomes interact with messenger RNA by complementary base pairing and that introns are spliced by small nuclear ribonucleic proteins (snRNPs), which occur in eukaryotes. In September 2018, Steitz won the Lasker-Koshland Award for Special Achievement in Medical Science. The Lasker award is often referred to as the 'American Nobel' because 87 of the former recipients have gone on to win Nobel prizes.

Sir Brian Mellor Greenwood, CBE, FRCP, FRS is a British physician, biomedical research scientist, academic, and recipient of the first Hideyo Noguchi Africa Prize.

<span class="mw-page-title-main">Shizuo Akira</span>

Shizuo Akira is a professor at the Department of Host Defense, Osaka University, Japan. He has made ground-breaking discoveries in the field of immunology, most significantly in the area of innate host defense mechanisms.

The Association of American Physicians (AAP) is an honorary medical society founded in 1885 by the Canadian physician Sir William Osler and six other distinguished physicians of his era for "the advancement of scientific and practical medicine."

Alan Bernstein is Professor Emeritus at the University of Toronto and President Emeritus of CIFAR, where he served as President and CEO from 2012 to 2022. A Distinguished Fellow at the Munk School of Global Affairs and Public Policy, he is also a Fellow and Member of the Standing Committee for Science Planning at the International Science Council (2022-2025). Bernstein is recognized as a leader in health research, science policy, mentorship and organizational leadership.

<span class="mw-page-title-main">Michael R. Hayden</span>

Michael R. Hayden, is a Killam Professor of Medical Genetics at the University of British Columbia, the highest honour UBC can confer on any faculty member. Only four such awards have ever been conferred in the Faculty of Medicine. Dr. Hayden is also Canada Research Chair in Human Genetics and Molecular Medicine. Hayden is best known for his research in Huntington disease (HD).

<span class="mw-page-title-main">Bruce William Stillman</span> Australian biochemist and cancer researcher

Bruce William Stillman, AO, FAA, FRS is a biochemist and cancer researcher who has served as the Director of Cold Spring Harbor Laboratory (CSHL) since 1994 and President since 2003. He also served as the Director of its NCI-designated Cancer Center for 25 years from 1992 to 2016. During his leadership, CSHL has been ranked as the No. 1 institution in molecular biology and genetics research by Thomson Reuters. Stillman's research focuses on how chromosomes are duplicated in human cells and in yeast Saccharomyces cerevisiae; the mechanisms that ensure accurate inheritance of genetic material from one generation to the next; and how missteps in this process lead to cancer. For his accomplishments, Stillman has received numerous awards, including the Alfred P. Sloan, Jr. Prize in 2004 and the 2010 Louisa Gross Horwitz Prize, both of which he shared with Thomas J. Kelly of Memorial Sloan-Kettering Cancer Center, as well as the 2019 Canada Gairdner International Award for biomedical research, which he shared with John Diffley.

<span class="mw-page-title-main">Foundation for the National Institutes of Health</span>

The Foundation for the National Institutes of Health (FNIH) is a not-for-profit, 501(c)(3) charitable organization established by the US Congress in 1990. Located in North Bethesda, MD, the FNIH raises private-sector funds, and creates and manages alliances with public and private institutions in support of the mission of the National Institutes of Health (NIH).

Antoine M. Hakim is a Canadian engineer and physician.

<span class="mw-page-title-main">William Kaelin Jr.</span> American Nobel Laureate, Professor of Medicine at Harvard University

William G. Kaelin Jr. is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.

The John Dirks Canada Gairdner Global Health Award is given by the Gairdner Foundation to recognize the world's top scientists who have made outstanding achievements in Global Health Research. Since its inception, the Global Health Award has grown significantly to become one of the world's most prestigious awards recognizing excellence in global health research.

Pieter Rutter Cullis is a Canadian physicist and biochemist known for his contributions to the field of lipid nanoparticles (LNP). Lipid nanoparticles are essential to current mRNA vaccines as a delivery system. Prof. Cullis is best known for the development of ionizable cationic lipids. These lipids are able to complex with negatively charged nucleic acids at low pH (≈4.0) where they are positively charged because they have a pKa if approximately 6.4. They reduce or eliminate toxicity associated with cationic lipids at physiological pH of 7.4 because they adopt a net neutral charge. Finally, they enable endosomal escape because they again become positively charged in acidified endosomes and promote formation of non-bilayer structures by interaction with negatively charged lipids. These properties are critical to the function of the mRNA vaccines and are rapidly enabling gene therapy in clinical settings.

References

  1. ↑ "About Gairdner".
  2. ↑ "Oakville Galleries".
  3. ↑ "Gairdner Foundation | About the Awards". gairdner.org. Retrieved 2017-05-03.
  4. ↑ "Gairdner Foundation | Our People". gairdner.org. Retrieved 2017-05-03.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.